Actively Recruiting
Integrated Harm Reduction Program vs Usual Services for Black and Latinx People Who Use Drugs to Improve Service Use
Led by NYU Langone Health · Updated on 2026-08-20
200
Participants Needed
3
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an integrated harm reduction intervention IHRI compared to usual harm reduction HR services for Black and Latinx people who use drugs. The study aims to see if the IHRI improves the use of harm reduction services among this group, focusing on those who misuse opioids and possibly other substances. This health services research is sponsored by NYU Langone Health and uses a randomized parallel design. The IHRI program lasts 8 weeks, beginning with 4 weekly education lessons led by a care coordinator. The next 4 weeks involve identifying social vulnerabilities to guide referrals to social service organizations. Both groups receive mobile van outreach offering information on syringe exchange, clean user kits, naloxone use, and fentanyl strip distribution. The comparison group receives the usual harm reduction services without the IHRI education or personalized referrals. Participants will be monitored for attendance at harm reduction sessions up to week 8. Researchers will assess changes in drug use days, overdose risk scores, and quality of life from baseline to week 8. The study includes interviews confirming substance misuse per DSM-5 criteria and requires informed consent. The trial runs from November 2024 to March 2028, with primary outcomes measured by week 8 and completion expected by October 2027.
CONDITIONS
Brief Title
Harm Reduction Services
Research Team
A
Ayana Jordan, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here